The World Health Organization has issued its first guidance on how three smallpox vaccines produced by commercial companies should be used for immunizing individuals exposed to or at risk of exposure to the monkeypox virus.
One of the vaccines, Bavarian Nordic A/S’s Imvanex/Jynneos (also known as MVA-BN), is authorized for smallpox and, since 2019 has also been authorized for monkeypox in the US and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?